[go: up one dir, main page]

ATE362107T1 - Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker - Google Patents

Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker

Info

Publication number
ATE362107T1
ATE362107T1 AT01989101T AT01989101T ATE362107T1 AT E362107 T1 ATE362107 T1 AT E362107T1 AT 01989101 T AT01989101 T AT 01989101T AT 01989101 T AT01989101 T AT 01989101T AT E362107 T1 ATE362107 T1 AT E362107T1
Authority
AT
Austria
Prior art keywords
prostate
markers
detection
quantitative detection
specific membrane
Prior art date
Application number
AT01989101T
Other languages
English (en)
Inventor
George Wright
Original Assignee
Eastern Virginia Med School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastern Virginia Med School filed Critical Eastern Virginia Med School
Application granted granted Critical
Publication of ATE362107T1 publication Critical patent/ATE362107T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G01N33/57555—
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Optics & Photonics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT01989101T 2000-11-20 2001-11-16 Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker ATE362107T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25245200P 2000-11-20 2000-11-20

Publications (1)

Publication Number Publication Date
ATE362107T1 true ATE362107T1 (de) 2007-06-15

Family

ID=22956064

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01989101T ATE362107T1 (de) 2000-11-20 2001-11-16 Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker

Country Status (9)

Country Link
EP (1) EP1390523B1 (de)
JP (1) JP2004536278A (de)
KR (1) KR20030066672A (de)
CN (1) CN1537170A (de)
AT (1) ATE362107T1 (de)
AU (2) AU2002243221B2 (de)
CA (1) CA2428011A1 (de)
DE (1) DE60128404D1 (de)
WO (1) WO2002046448A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050215472A1 (en) 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
EP2360169B1 (de) 2001-10-23 2015-10-14 Psma Development Company, L.L.C. PSMA Antikörper
GB0305656D0 (en) * 2003-03-12 2003-04-16 Bioinvent Int Ab Screening assay
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
EP1999136B1 (de) * 2006-03-14 2012-10-24 Cancer Targeted Technology LLC Peptidomimetische hemmer von psma, verbindungen damit und anwendungsverfahren dafür
WO2007129751A1 (ja) * 2006-05-10 2007-11-15 Aska Pharmaceutical Co., Ltd. 前立腺癌と良性前立腺過形成の鑑別法
US8586006B2 (en) * 2006-08-09 2013-11-19 Institute For Systems Biology Organ-specific proteins and methods of their use
CN101158666B (zh) * 2006-10-08 2012-06-27 许洋 一种用含有抗体组的基质去捕获生物样品中生物标志的分析方法
WO2008110006A1 (en) 2007-03-12 2008-09-18 Miraculins Inc. Biomarkers of prostate cancer and uses thereof
WO2008136912A1 (en) 2007-05-07 2008-11-13 Massachusetts Institute Of Technology Polymer sheets and other bodies having oriented chains and method and apparatus for producing same
WO2010006048A2 (en) * 2008-07-08 2010-01-14 Source Precision Medicine, Inc. Gene expression profiling for predicting the survivability of prostate cancer subjects
EP3495000A1 (de) * 2009-02-17 2019-06-12 Cornell Research Foundation, Inc. Verfahren und kits zur diagnose von krebs und vorhersage des therapeutischen werts
JP5222906B2 (ja) * 2010-07-20 2013-06-26 株式会社日立ハイテクノロジーズ 生体試料の分析方法
CN102998448A (zh) * 2011-09-09 2013-03-27 上海市计划生育科学研究所 来源于前列腺分泌液中的前列腺癌标记物
CN102409091A (zh) * 2011-10-17 2012-04-11 刘颜 前列腺分泌蛋白94/57作为卵巢癌、乳腺癌早期临床诊断生物标记物的方法
FI3312749T3 (fi) 2012-03-05 2024-05-31 Oy Arctic Partners Ab Menetelmiä ja laitteita eturauhassyövän riskin ja eturauhasen tilavuuden ennustamiseen
JP5429725B1 (ja) * 2013-03-22 2014-02-26 独立行政法人理化学研究所 前立腺癌の進行度の評価方法、前立腺癌の検出方法、および検査キット
EP2806275B1 (de) * 2013-05-23 2015-07-01 Bruker Daltonik GmbH Massenspektrometrische Resistenzbestimmung durch Wachstums-Messung
US12326453B2 (en) 2014-03-28 2025-06-10 Opko Diagnostics, Llc Compositions and methods for active surveillance of prostate cancer
EP3299977A1 (de) 2014-03-28 2018-03-28 Opko Diagnostics, LLC Zusammensetzungen und verfahren in zusammenhang mit der diagnose von prostatakrebs
GB2535835B (en) * 2014-12-17 2019-09-04 Micromass Ltd A two-dimensional separation and imaging technique for the rapid analysis of biological samples
JP6749337B2 (ja) 2015-03-27 2020-09-02 オプコ・ダイアグノスティクス・リミテッド・ライアビリティ・カンパニーＯｐｋｏ Ｄｉａｇｎｏｓｔｉｃｓ，Ｌｌｃ 前立腺抗原標準およびその使用
WO2021026172A1 (en) 2019-08-05 2021-02-11 Seer, Inc. Systems and methods for sample preparation, data generation, and protein corona analysis
GB202111635D0 (en) * 2021-08-13 2021-09-29 Randox Laboratories Risk prediction model for prostate cancer
CN114292918A (zh) * 2021-12-31 2022-04-08 刘飞 一种基于LncRNA546标志物的前列腺癌早期诊断方法
CN115711933A (zh) * 2022-11-10 2023-02-24 广东省人民医院 检测试剂、检测试剂盒及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4204642B2 (ja) * 1992-11-05 2009-01-07 スローン − ケタリング・インスティテュート・フォー・キャンサー・リサーチ 前立腺に特異的な膜抗原
AU6551398A (en) * 1997-03-11 1998-09-29 Anna C. Ferrari Method of detecting prostate cancer metastasis
WO2000050457A1 (en) * 1999-02-22 2000-08-31 Beckman Coulter, Inc. Prostate-specific membrane antigens and methods of making and using
CN1426536A (zh) * 2000-03-20 2003-06-25 东弗吉尼亚医学院 前列腺癌标记
US6379550B1 (en) * 2000-07-24 2002-04-30 Health Research, Inc. Method for detecting PSA and its molecular forms using thiophilic gel

Also Published As

Publication number Publication date
CN1537170A (zh) 2004-10-13
KR20030066672A (ko) 2003-08-09
WO2002046448A2 (en) 2002-06-13
AU2002243221B2 (en) 2006-11-09
DE60128404D1 (de) 2007-06-21
JP2004536278A (ja) 2004-12-02
EP1390523B1 (de) 2007-05-09
CA2428011A1 (en) 2002-06-13
EP1390523A4 (de) 2004-03-31
WO2002046448A3 (en) 2003-12-11
AU4322102A (en) 2002-06-18
EP1390523A2 (de) 2004-02-25

Similar Documents

Publication Publication Date Title
ATE362107T1 (de) Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker
DE60029369D1 (de) Verfahren und Sondenset zur Erkennung von Krebs
WO2005019477A3 (en) Methods and compositions for differentiating tissues or cell types using epigenetic markers
ATE469219T1 (de) Zusammensetzungen, methoden und reagentien zur nukleinsäureisolierung mittels oberflächenaktiven substanzen und proteasen
ATE212674T1 (de) Verfahren und analytisches system zur genauen schnellen und einfachen ausführung von fibrinogen-assays
ATE350488T1 (de) Verfahren und testsysteme zur identifizierung von elite event gat-zm1 in biologischen proben
DE50113548D1 (de) Verfahren zum Nachweis von Influenza A/B-Viren in Speichel
ATE462492T1 (de) Vorrichtung zur detektion von targetmolekülen
DE59609347D1 (de) Verfahren zur quantifizierung von tumorzellen in einer körperflüssigkeit und dazu geeignete testkits
GB2431988A (en) Assay device & method
WO2006047484A3 (en) Molecular analysis of cellular fluid and liquid cytology specimens for clinical diagnosis, characterization, and integration with microscopic pathology evaluation
EP1362124A4 (de) Verfahren und sonden für den nachweis von krebs
AU2002303444A1 (en) Detection of microsatellite instability and its use in diagnosis of tumors
DK0975800T3 (da) Analyse af nukleotider i opløsning under anvendelse af PNA-prober
WO2002048674A3 (en) Methods, devices, arrays and kits for detecting and analyzing biomolecules
IL157917A0 (en) Method for sample identification in a mammal as well as a kit for performing this method
BRPI0414283A (pt) métodos, composições e kits para a concentração e detecção de microorganismos
EP1392362A4 (de) Nachweis von legionella mit echtzeit-pcr und fluoreszenz-resonanz-energie-transfer
ATE541945T1 (de) Nachweis und quantifizierung fäkaler verunreinigungen in umweltproben
ATE272718T1 (de) Verfahren zur bestimmung von disaccharidasen
DE50110172D1 (de) Verfahren zur altersbestimmung von individuen
SE0002287D0 (sv) Biotinderivat
DK1337849T3 (da) Fremgangsmåder og sammensætninger til at sortere og/eller bestemme mikroorganismer
DE60109733D1 (de) Verfahren zur immobilisierung von affinen reagentien an hydrophoben festphasen
PT1218749E (pt) Sistema de deteccao de cancro da prostata atraves da analise do psa/igf-l livre

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties